Kevin Gianaris1, Grecia B Vargas2, Morgan Johnson1, Yifan Yu1, Elena Wilson1, Jamilah A Perkins1, Aswad Jackson3, L Ebony Boulware4, Allan Massie1,5, Macey L Levan1, Dorry L Segev1,5, Tanjala S Purnell1,2,5. 1. Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD. 2. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 3. Diversity Summer Internship Program, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 4. Division of General Internal Medicine, Duke University School of Medicine, Durham, NC. 5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Abstract
Background: Despite the societal benefits of live kidney donation, Black donors may be more likely than White donors to develop hypertension (HTN) and chronic kidney disease after donation. Among live kidney donors diagnosed with post-donation HTN, little is known about potential racial/ethnic differences in HTN self-care behaviors and perceived susceptibility to developing kidney disease. Methods: We ascertained electronic medical records and phone survey data from live donors enrolled in the multi-center Wellness and Health Outcomes of LivE Donors (WHOLE-Donor) Hypertension Care Study between May 2013 and April 2020. Using multivariable logistic regression models performed January through June 2021, we examined potential associations of donor race/ethnicity with perceived susceptibility to kidney disease and self-care behaviors (ie, Behavioral Risk Factor Surveillance System measure assessing self-reported actions to control high blood pressure). Results: The study included 318 US-based live kidney donors who developed post-donation HTN (57.6% female; 78.9% White; 18.6% Black; and mean age 46.7 years at donation). Black donors were equally as likely as White donors to report being moderately or strongly concerned about developing kidney disease (adjusted odds ratio, aOR: 1.27, 95%CI: .66, 2.14, P=.57). Donors with diabetes were more likely than those without diabetes (aOR: 2.43, 95%CI: 1.03, 5.01, P=.04), while donors aged >50 years were less likely than younger donors (aOR: .39, 95%CI: .18, .85, P=.02) to report being moderately or strongly concerned about kidney disease. Overall, 87% of donors reported taking at least one action to help control blood pressure, with no significant differences by sociodemographic factors. Conclusions: We found no substantial differences in perceived susceptibility to kidney disease among Black and White donors, despite published evidence that Black donors may experience greater risk of developing kidney disease than White donors. Behavioral interventions to enhance knowledge about future disease risk, attitudes, and self-care strategies among living kidney donors may be beneficial.
Background: Despite the societal benefits of live kidney donation, Black donors may be more likely than White donors to develop hypertension (HTN) and chronic kidney disease after donation. Among live kidney donors diagnosed with post-donation HTN, little is known about potential racial/ethnic differences in HTN self-care behaviors and perceived susceptibility to developing kidney disease. Methods: We ascertained electronic medical records and phone survey data from live donors enrolled in the multi-center Wellness and Health Outcomes of LivE Donors (WHOLE-Donor) Hypertension Care Study between May 2013 and April 2020. Using multivariable logistic regression models performed January through June 2021, we examined potential associations of donor race/ethnicity with perceived susceptibility to kidney disease and self-care behaviors (ie, Behavioral Risk Factor Surveillance System measure assessing self-reported actions to control high blood pressure). Results: The study included 318 US-based live kidney donors who developed post-donation HTN (57.6% female; 78.9% White; 18.6% Black; and mean age 46.7 years at donation). Black donors were equally as likely as White donors to report being moderately or strongly concerned about developing kidney disease (adjusted odds ratio, aOR: 1.27, 95%CI: .66, 2.14, P=.57). Donors with diabetes were more likely than those without diabetes (aOR: 2.43, 95%CI: 1.03, 5.01, P=.04), while donors aged >50 years were less likely than younger donors (aOR: .39, 95%CI: .18, .85, P=.02) to report being moderately or strongly concerned about kidney disease. Overall, 87% of donors reported taking at least one action to help control blood pressure, with no significant differences by sociodemographic factors. Conclusions: We found no substantial differences in perceived susceptibility to kidney disease among Black and White donors, despite published evidence that Black donors may experience greater risk of developing kidney disease than White donors. Behavioral interventions to enhance knowledge about future disease risk, attitudes, and self-care strategies among living kidney donors may be beneficial.
Authors: David J Taber; Nicole A Pilch; John W McGillicuddy; Caitlin Mardis; Frank Treiber; James N Fleming Journal: Am J Health Syst Pharm Date: 2019-07-18 Impact factor: 2.637
Authors: Allan B Massie; Abimereki D Muzaale; Xun Luo; Eric K H Chow; Jayme E Locke; Anh Q Nguyen; Macey L Henderson; Jon J Snyder; Dorry L Segev Journal: J Am Soc Nephrol Date: 2017-04-27 Impact factor: 10.121
Authors: Courtenay M Holscher; Christine E Haugen; Kyle R Jackson; Jacqueline M Garonzik Wang; Madeleine M Waldram; Sunjae Bae; Jayme E Locke; Rhiannon D Reed; Krista L Lentine; Gaurav Gupta; Matthew R Weir; John J Friedewald; Jennifer Verbesey; Matthew Cooper; Dorry L Segev; Allan B Massie Journal: Clin J Am Soc Nephrol Date: 2019-09-19 Impact factor: 8.237
Authors: Tanjala S Purnell; Elizabeth A Calhoun; Sherita H Golden; Jacqueline R Halladay; Jessica L Krok-Schoen; Bradley M Appelhans; Lisa A Cooper Journal: Health Aff (Millwood) Date: 2016-08-01 Impact factor: 6.301
Authors: Tanjala S Purnell; Xun Luo; Lisa A Cooper; Allan B Massie; Lauren M Kucirka; Macey L Henderson; Elisa J Gordon; Deidra C Crews; L Ebony Boulware; Dorry L Segev Journal: JAMA Date: 2018-01-02 Impact factor: 56.272
Authors: Abimereki D Muzaale; Allan B Massie; Mei-Cheng Wang; Robert A Montgomery; Maureen A McBride; Jennifer L Wainright; Dorry L Segev Journal: JAMA Date: 2014-02-12 Impact factor: 56.272
Authors: Amy D Waterman; Teri Browne; Brian M Waterman; Elisa H Gladstone; Thomas Hostetter Journal: Am J Kidney Dis Date: 2008-03-06 Impact factor: 8.860
Authors: Krista L Lentine; Mark A Schnitzler; Amit X Garg; Huiling Xiao; David Axelrod; Janet E Tuttle-Newhall; Daniel C Brennan; Dorry L Segev Journal: Am J Nephrol Date: 2014-09-02 Impact factor: 3.754